Klotho Neurosciences Wins the 2025 BioTech Breakthrough 'Cell Therapy Innovation of the Year' Award

Written by Emily J. Thompson, Senior Investment Analyst

Source: PRnewswire

Updated: Nov 07 2025

0mins

Source: PRnewswire

Award Recognition: Klotho Neurosciences, Inc. has won the Fifth Annual BioTech Breakthrough Award for "Cell Therapy Innovation of the Year" for its groundbreaking work in gene and cell therapies targeting neurodegenerative diseases.
Innovative Therapies: The company focuses on using a patented form of the human Klotho gene (s-KL) to develop therapies aimed at slowing or reversing diseases like ALS, Alzheimer's, and Parkinson's, addressing the root causes of neuronal aging.
Commitment to Patients: CEO Dr. Joseph Sinkule emphasized the importance of developing therapies that improve health span and reduce the burden of age-related diseases, especially as the global population ages.
BioTech Breakthrough Awards: The awards program recognizes innovative companies and technologies in the life sciences and biotechnology sectors, celebrating excellence in various fields including biopharma and therapeutics.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

GET FREE REAL TIME NOTIFICATIONS

Stock Monitor for NVDA?

Get Started Free

FREE STOCK RECOMMENDATIONS DAILY

Stock Bullish Tomorrow

Get Started Free

70% BACKTESTED ACCURACY!

Should I Buy NVDA?

Get Started Free